HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leptin and soluble leptin receptor in risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

Abstract
Leptin, a peptide hormone produced primarily by the adipocytes, is hypothesized to play a role in the pathogenesis of colorectal cancer (CRC). Soluble leptin receptor (sOB-R) may regulate leptin's physiologic functions; however its relation to CRC risk is unknown. This study explored the association of leptin and sOB-R with risk of CRC in a prospective nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 1,129 incident CRC cases (713 colon, 416 rectal) were matched within risk sets to 1,129 controls. Conditional logistic regression was used to calculate relative risks (RR) and 95% confidence intervals (CI). After multivariable adjustment including body mass index (BMI), waist circumference, and baseline leptin concentrations, sOB-R was strongly inversely associated with CRC (RR comparing the highest quintile vs. the lowest, 0.55; 95% CI, 0.40-0.76; P(trend) = 0.0004) and colon cancer (RR, 0.42; 95% CI, 0.28-0.63, P(trend) = 0.0001); whereas no association was seen for rectal cancer (RR adjusted for BMI and waist circumference, 0.83; 95% CI, 0.48-1.44, P(trend) = 0.38). In contrast, leptin was not associated with risk of CRC (RR adjusted for BMI and waist circumference, 0.85; 95% CI, 0.56-1.29, P(trend) = 0.23). Additional adjustments for circulating metabolic biomarkers did not attenuate these results. These novel findings suggest a strong inverse association between circulating sOB-R and CRC risk, independent of obesity measures, leptin concentrations, and other metabolic biomarkers. Further research is needed to confirm the potentially important role of sOB-R in CRC pathogenesis.
AuthorsKrasimira Aleksandrova, Heiner Boeing, Mazda Jenab, H Bas Bueno-de-Mesquita, Eugene Jansen, Fränzel J B van Duijnhoven, Sabina Rinaldi, Veronika Fedirko, Isabelle Romieu, Elio Riboli, Marc J Gunter, Sabine Westphal, Kim Overvad, Anne Tjønneland, Jytte Halkjær, Antoine Racine, Marie-Christine Boutron-Ruault, Françoise Clavel-Chapelon, Rudolf Kaaks, Annekatrin Lukanova, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Amalia Mattiello, Valeria Pala, Domenico Palli, Rosario Tumino, Paolo Vineis, Genevieve Buckland, María-José Sánchez, Pilar Amiano, José María Huerta, Aurelio Barricarte, Virginia Menéndez, Petra H Peeters, Stefan Söderberg, Richard Palmqvist, Naomi E Allen, Francesca L Crowe, Kay-Tee Khaw, Nickolas Wareham, Tobias Pischon
JournalCancer research (Cancer Res) Vol. 72 Issue 20 Pg. 5328-37 (Oct 15 2012) ISSN: 1538-7445 [Electronic] United States
PMID22926557 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Leptin
  • Receptors, Leptin
Topics
  • Adult
  • Aged
  • Cohort Studies
  • Colorectal Neoplasms (physiopathology)
  • Europe
  • Female
  • Humans
  • Leptin (physiology)
  • Male
  • Middle Aged
  • Nutritional Status
  • Prospective Studies
  • Receptors, Leptin (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: